Cargando…
Loss of AMPKα2 promotes melanoma tumor growth and brain metastasis
AMP-activated protein kinase (AMPK) is a critical cellular energy sensor at the interface of metabolism and cancer. However, the role of AMPK in carcinogenesis remains unclear. Here, through analysis of the TCGA melanoma dataset, we found that PRKAA2 gene that encodes the α2 subunit of AMPK is mutat...
Autores principales: | Yuan, Ping, Teng, Da, de Groot, Evelyn, Li, Man, Trousil, Sebastian, Shen, Che-Hung, Roszik, Jason, Davies, Michael A., Gopal, Y.N. Vashisht, Zheng, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197146/ https://www.ncbi.nlm.nih.gov/pubmed/37213225 http://dx.doi.org/10.1016/j.isci.2023.106791 |
Ejemplares similares
-
Counteracting oxidative phosphorylation-mediated resistance of melanomas to MAPK pathway inhibition
por: McQuade, Jennifer L, et al.
Publicado: (2015) -
Loss of cohesin complex components STAG2 or STAG3 confers resistance to BRAF inhibition in melanoma
por: Shen, Che-Hung, et al.
Publicado: (2016) -
RMEL3, a novel BRAF(V600E)-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma
por: Goedert, Lucas, et al.
Publicado: (2016) -
Combined inhibition of HMGCoA reductase and mitochondrial complex I induces tumor regression of BRAF inhibitor-resistant melanomas
por: de Groot, Evelyn, et al.
Publicado: (2022) -
Loss of AMPKα2 Impairs Hedgehog-Driven Medulloblastoma Tumorigenesis
por: Zhang, Honglai, et al.
Publicado: (2018)